-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Downgrades Pfizer to Hold, Lowers Price Target to $28

Benzinga·07/06/2026 09:53:15
Listen to the news
HSBC analyst Rajesh Kumar downgrades Pfizer (NYSE:PFE) from Buy to Hold and lowers the price target from $32 to $28.